AstraZeneca
The Director of Vector Engineering at EsoBiotec, part of AstraZeneca, is responsible for leading innovation in lentiviral vector platforms within the field of cell and gene therapy. The role involves setting strategic direction, overseeing discovery and development processes, managing collaborations, and contributing to patent and publication efforts, all to advance therapeutic products.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Scientific Director Genomic Medicines (f/m/d)
Cepheid
Master Thesis
Leica Biosystems
Senior Research Associate – Scientist II, Molecular Biology & Viral Vector Platforms
Adicet Bio
Postdoctoral Fellow in Pediatrics
PeopleAdmin
Director of Vector Engineering and Manufacturing Quality - Cell Therapy
Marriott International
Scientist, In Vivo CAR-T Pipeline
Legend Biotech